HM Payson & Co’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$118K Buy
303
+291
+2,425% +$123K ﹤0.01% 544
2026
Q1
$5.68K Hold
12
﹤0.01% 965
2025
Q4
$5.6K Hold
12
﹤0.01% 971
2025
Q3
$5.12K Hold
12
﹤0.01% 946
2025
Q2
$4.6K Sell
12
-7
-37% -$2.52K ﹤0.01% 884
2025
Q1
$6.57K Hold
19
﹤0.01% 894
2024
Q4
$5.7K Sell
19
-1
-5% -$349 ﹤0.01% 889
2024
Q3
$8.13K Buy
+20
New +$7.32K ﹤0.01% 858
2023
Q3
Sell
-31
Closed -$9.41K 1024
2023
Q2
$9.41K Buy
+31
New +$8.62K ﹤0.01% 811
2022
Q3
Sell
-2
Closed 1030
2022
Q2
$0 Hold
2
﹤0.01% 1083
2022
Q1
$1K Hold
2
﹤0.01% 1013
2021
Q4
$1K Hold
2
﹤0.01% 1043
2021
Q3
$0 Hold
2
﹤0.01% 1103
2021
Q2
$0 Hold
2
﹤0.01% 1124
2021
Q1
$0 Buy
+2
New +$353 ﹤0.01% 1142
2019
Q3
Sell
-26
Closed -$4K 952
2019
Q2
$4K Buy
+26
New +$3.29K ﹤0.01% 884

Other funds holding HCA

HM Payson & Co's HCA Position: Q2 2026 in Review

HM Payson & Co increased its HCA Healthcare (HCA) stake by 2,425% in Q2 2026, buying an estimated $123K and bringing the position to 303 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #544.

HM Payson & Co first reported a position in HCA in Q2 2019 and has held it in 16 quarters since. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • HM Payson & Co held 303 shares of HCA Healthcare worth $118K as of Q2 2026.
  • HM Payson & Co bought 291 HCA Healthcare shares in Q2 2026, an estimated $123K.
  • HCA Healthcare made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #544 holding.
  • HM Payson & Co first reported a position in HCA Healthcare in Q2 2019 and has held it in 16 quarters since.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.